Analytical Methods4 min read
Peptide Charge States and Adducts: Reading an ESI Mass Spectrum

Several peaks in a peptide ESI mass spectrum do not necessarily represent several compounds. Electrospray ionization can produce multiple charged forms of one peptide, and additional associated species can generate adduct signals. Interpreting the spectrum starts with assigning those ions, not counting peaks as separate materials.
Several peaks in a peptide ESI mass spectrum do not necessarily represent several compounds. Electrospray ionization can produce multiple charged forms of one peptide, and additional associated species can generate adduct signals. Interpreting the spectrum starts with assigning those ions, not counting peaks as separate materials.
The practical goal is to determine which observed signals can reasonably belong to the proposed peptide and which remain unexplained. That requires the raw spectrum, its acquisition context, and a transparent record of any deconvolution.
Understand the role of charge
A positive ion carrying several charges appears at a different m/z than a singly charged form of the same neutral molecule. For an ion carrying only added protons, the usual relationship adds the mass of those protons to the neutral mass and divides by the charge count.
The NIST Mass and Fragment Calculator description illustrates that calculated peptide mass and charge-specific m/z values are separate outputs. The calculation assumes a defined ion composition; it should not be applied unchanged to every adduct.
Record charge assignments explicitly. A table that lists several m/z values without charge information may make one peptide look like several unrelated substances.
Recognize that ionization conditions matter
Waters' guide to mass-directed peptide analysis describes how peptide charge states depend on factors including solution conditions and molecular functional groups. An ion distribution observed in one method therefore need not match a distribution from another method exactly.
For a comparison, retain the ionization mode, solvent system, instrument method, and sampled chromatographic region. Compare observations made under suitably matched conditions before interpreting relative peak abundance.
An unexpectedly weak charge state can justify checking the method. It is not automatically evidence that the sequence is absent.
Treat an adduct label as an assignment
Adduct terminology describes an associated ion composition. It should not become a convenient name for any unexplained neighboring peak. Ask whether the proposed mass difference, charge, isotope pattern, and chromatographic behavior support the assignment.
For a hypothetical sample, two signals might be explained by protonated and metal-associated ion forms of the same peptide. That explanation becomes more credible when several observations agree. A software label on its own is weaker evidence.
Keep the proposed adduct identity and the basis for it in separate fields. Where the evidence is incomplete, use a qualified label such as “candidate adduct” and identify what additional measurement would resolve it.
Review deconvolution alongside the raw data
Deconvolution converts an ion pattern into inferred mass information using a model and software settings. The resulting simplified plot can be helpful, but it should remain connected to the original spectrum.
Check the selected time window, charge range, background treatment, and any processing thresholds relevant to the method. In a mixed chromatographic region, a clean-looking processed output may conceal uncertainty about which signals were combined.
Ask the analyst to demonstrate the link between a reported mass and the contributing ions. This is particularly useful when a result changes after reprocessing the same acquisition. Preserve both processing versions and explain the reason for the change.
Report what remains unresolved
A useful report separates assigned peptide ions, plausible associated species, and unassigned signals. It also states the limitations of the method rather than converting every remaining signal into an impurity claim.
The site's quality and documentation page can help organize requests for available analytical information. Supply the product identifier and report reference when contacting the team, and ask which underlying data or method details can be provided.
The strongest outcome is an explainable spectrum: the interpretation can be traced from raw signals through ion assignments to the final reported mass, with uncertainty visible at each stage.
Related reading
Continue with Monoisotopic vs Average Peptide Mass: Comparing the Right Numbers; Peptide MS/MS Sequence Coverage: What Fragment Ions Establish; Stable Isotope-Labeled Peptides: Choosing an Internal Standard.
For in vitro laboratory research use only. Not for human or animal use or consumption. Not for diagnostic or therapeutic use.


